RESULTS: Overall, 3417 participants underwent randomization
OpenLoop Health provides the network of US-licensed physicians who evaluate patient-submitted health information and determine whether compounded GLP-1 medications are medically appropriate, with prescribing authority remaining solely with licensed clinicians
If this matters to you, the premium pricing may represent good value
Clinical Trial Results STEP trials (Semaglutide Treatment Effect in People with obesity): Average weight loss of ~15% of total body weight
Not intended for human or animal consumption, nor for medical, veterinary, or therapeutic use
Case Report A 73-year-old female with type 2 diabetes, hyperlipidemia, depression, and obesity (BMI 38.5) presented with worsening abdominal pain for three days